Blog - Page 2531 of 5709

FridayNov 18, 2016 10:17 am

Discuss Your Favorite Stocks with Like-Minded Investors at The QualityStocks Message Boards

QualityStocks has completely overhauled its stock community forum. Members now have more control over customization as well as many new features available to them. Searching has also been optimized, allowing users to quickly search the message board community for posts related to a certain stock symbol or other keyword. The message board community at QualityStocks is one of the most highly regulated, no-nonsense forums online today; an uncommon haven of highly relevant, SPAM-free investor interaction. Unlike the majority of boards currently in operation, you won’t find pumping, bashing, advertising, or malicious posting of any kind here. To join our thousands…

ThursdayNov 17, 2016 4:54 pm

Inovio Pharmaceuticals, Inc. (INO) opens New Front Line in War against Cancer & Infectious Diseases with DNA Vaccines

Over 2,000 years ago, Plato, in his immortal Socratic dialogue, had the great philosopher express his astonishment at the new diseases plaguing Athenian society and their bizarre and horrible names. Our position today is very similar. Strange, horrible afflictions with bizarre, frightening names like cancer, Ebola and Zika, unknown or unrecognized until modern times, threaten us with epidemics and pandemics. For a hundred years or so, we’ve fought them off with traditional vaccines and pharmaceuticals. Now, a new battlefront is set to open with the advent of DNA vaccines from companies like Inovio Pharmaceuticals, Inc. (NASDAQ: INO). Traditional vaccines stimulate…

ThursdayNov 17, 2016 3:31 pm

Aegis Capital Supports ‘Buy’ Rating, Higher Stock Price Target for Progenics (PGNX) Following Strong Q3 Results

Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX), a company focused on the development of innovative treatments and therapies for cancer, in particular prostate cancer, recently released its financial results for the third quarter of 2016, reporting higher revenue and net income compared to the third quarter of 2015. The growth can be primarily attributed to the FDA approval and U.S. commercial launch of its flagship product, oral Relistor®, for the treatment of opioid induced constipation in patients suffering from chronic non-cancer pain, according to an Aegis Capital Corp. analysis (http://dtn.fm/8EJce) released on November 8, one day after the Q3 results. The Aegis…

ThursdayNov 17, 2016 3:07 pm

Nektar Therapeutics (NKTR) is “One to Watch”

Nektar Therapeutics (NASDAQ: NKTR), a biopharmaceutical company in the business of developing new medicines for people living with life changing conditions, now helps more than nine million patients worldwide. Nektar also offers a proprietary pipeline made up of drug candidates for oncology, pain, anti-infectives, and immunology. The company has 12 approved products, including Movantik, Adynovate, and Onzeald. Movantik, which is used for the treatment of opioid induced constipation, was approved for sale in both the U.S. and Europe in 2014, allowing Nektar to see a significant increase in sales and royalty payments. Adynovate, used in the treatment of hemophilia A…

ThursdayNov 17, 2016 1:51 pm

Singlepoint, Inc. (SING) Subsidiary SingleSeed Aiming to Help Cannabis Business Owners Thrive

The U.S. cannabis market is expected to continue and even speed up its exponential growth as a result of last week’s vote to legalize recreational or medical marijuana in eight more states. This is good news for an industry that is already growing at a fast pace, being set to exceed $7 billion this year, according to ArcView Research estimates. The trend is likely to continue, as experts predict the marijuana market to reach roughly $22 billion by 2020 and $50 billion by 2026. But even if the market is growing so quickly, legal businesses operating in the sector still…

ThursdayNov 17, 2016 1:26 pm

Monaker Group (MKGI) Set to Capitalize on This Year’s Thanksgiving Celebrations

This Thanksgiving, AAA, North America’s largest motoring and leisure travel organization, is expecting over one million more Americans to travel. According to the company’s 2016 Thanksgiving Holiday Travel Forecast, there will be more than 48.7 million travelers, marking the highest Thanksgiving holiday travel volume since 2007. Travel has gone up 1.9% this year alone, leading to a 29% increase of travelers during Thanksgiving over the past eight years. According to the report and its attached infographic, 89.4% of people will be traveling by car, a 12.5% increase from the 2001 to 2015 average. In addition, air travel has risen 10%…

ThursdayNov 17, 2016 11:16 am

GainClients, Inc. (GCLT) Announces Continued Partnership with Largest Real Estate Customer

Before the opening bell, GainClients, Inc. (OTC: GCLT) announced its continued partnership with Wardley Real Estate, the company’s largest real estate customer. Wardley originally implemented GainClients’ innovative GCard platform during its semi-annual technology rally in April 2015, when it introduced approximately 275 of its agents to the benefits of the GCard. Since that time, the number of Wardley agents leveraging the GCard to build industry relationships and enhance sales has grown to roughly 375 throughout the states of Utah, Colorado and Nevada. “We are very pleased to continue our relationship with the Wardley Real Estate Company,” Ray Desmond, president and…

ThursdayNov 17, 2016 10:13 am

Medical Transcription Billing, Corp. (MTBC) mHealth Keeping Patients and Practices Constantly Connected

As part of its constant efforts to offer one of the most comprehensive suites of electronic health records, practice management and revenue cycle solutions on the market, Medical Transcription Billing, Corp. (NASDAQ: MTBC; MTBCP) provides its customers with a comprehensive suite of mobile health applications designed to significantly improve patient engagement and give practices secure and consistent access to real-time information. The native mobile applications offered under the mHealth umbrella are designed for a wide variety of tablet devices and smartphones and are fully integrated with the company’s core suite of services and products. One of the most inclusive apps…

ThursdayNov 17, 2016 9:00 am

QualityStocksNewsBreaks – Wildflower Brands Inc.’s (CSE: SUN) (OTCQB: WLDFF) Disposable Vaporizers Highlighted on Leafly.com

Wildflower Brands (CSE: SUN) (OTCQB: WLDFF) was featured in an article on Leafly titled ‘Product Review: The Wildflower Disposable Vape Pen’ authored by Darren Harris. The article features Wildflower's hybrid strain THC disposable vape pen, Eclipse. Consumers benefit from the discreetness of the pen while enjoying a powerful and smooth draw each time. The Eclipse pen is disposable and requires no charging, appealing to first time users and those who need a light and pleasant boost throughout the day. The article also features Wildflower's non-THC disposable pens, Aches and Immunity, which include not only CBD, but a unique blend of…

WednesdayNov 16, 2016 4:32 pm

eXp World Holdings, Inc. (EXPI) Gearing Up to Serve Generation Z

Recently there has been a lot of talk about Generation Z from real estate sources such as The National Association of Realtors (NAR), DS News, and 8Z Real Estate, effectively stating that “Nearly All of Generation Z Sees Homeownership in Their Future.” Although the focus has often been on millennials when it comes to home ownership, DS News (http://dtn.fm/9gGFs) asked its readers some key questions: “What about the generation that follows behind Millennials? What are those from Generation-Z, or those born after 1996, planning when it comes to becoming future homeowners?” An NAR article entitled 'Nearly All of Generation Z…

Site Search

Company Search